
Midyear 2026 Check-In: Megha Sinha on Pharma's AI Skills Gap
Megha Sinha, Kolter AI, talks on how orchestrator roles surged in pharma AI, but teams need computed plans, not titles, to close the skills gap.
In part 2 of a 3-part interview, Megha Sinha, founder and CEO of Kolter AI
Sinha says that is now shifting as pharma companies bring engines like Kolter AI into live programs, computing an entire cross-market change, including filings, label updates, and country-by-country implementation waves, before a single affiliate is contacted. Local teams then validate a computed plan rather than building one from scratch over months, a shift she frames as a change in the job itself, from constructing plans to interrogating them.
She also pushes back on industry timelines that place connected, cross-functional orchestration a decade out. "The connective tissue that everyone described as years away is exactly what we built," Sinha says, describing the missing piece as automated impact assessment spanning regulatory, quality, manufacturing, and labeling functions. Companies approaching Kolter AI, she says, aren't asking whether this kind of orchestration is possible after years of doing it manually. They're asking how quickly they can adopt it, which Sinha takes as confirmation that the shift from aspiration to operational reality is already underway.




